![](/OA_MEDIA/jtfutrpx.gif) |
|
Please log in to determine if you are eligible to purchase PT Programs.
|
![](/OA_MEDIA/jtfutrpx.gif) |
MINIMAL RESIDUAL DISEASE, PML/RARA - MRD2 |
MRD2
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
Program Information
- Three RNA specimens in sterile water
- For laboratories diagnosing and monitoring leukemia tumor burden by measuring the quantity of PML/RARA fusion transcripts
- Ships on dry ice
Shipping Schedule
-
Shipment A: April 19
-
Shipment B: October 4
|
|
![](/OA_MEDIA/jtfutrpx.gif) |
|
![](/OA_MEDIA/jtfutrpx.gif) |
|